Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Postinjury fibrinolysis shutdown: Rationale for selective tranexamic acid

Moore, Ernest E. MD; Moore, Hunter B. MD; Gonzalez, Eduardo MD; Chapman, Michael P. MD; Hansen, Kirk C. PhD; Sauaia, Angela MD, PhD; Silliman, Christopher C. MD, PhD; Banerjee, Anirban PhD

Journal of Trauma and Acute Care Surgery: June 2015 - Volume 78 - Issue 6 - p S65–S69
doi: 10.1097/TA.0000000000000634
Review Articles

From the Departments of Surgery (E.E.M., H.B.M., E.G., M.P.C., K.C.H., A.S., A.B.) and Pediatrics (C.C.S.), University of Colorado Denver, Aurora; Department of Surgery (E.E.M., H.B.M., E.G., M.P.C., A.S.), Denver Health Medical Center; and Bonfils Blood Center (C.C.S.), Denver, Colorado.

Submitted: September 2, 2014, Revised: January 20, 2015, Accepted: February 2, 2015.

Presented at the 4th Annual Remote Damage Control Resuscitation Symposium of the Trauma Hemostasis and Oxygenation Research Network, June 9–11, 2014, in Bergen, Norway.

Address for reprints: Ernest E. Moore, MD, Department of Surgery, Denver Health Medical Center, 777 Bannock St., Denver, CO 80204; email: ernest.moore@dhha.org.

© 2015 Lippincott Williams & Wilkins, Inc.